Dazodalibep
Horizon Therapeutics
['dazodalibep', '$hznp']
$hznp presentations at the 2023 eular european congress of rheumatology highlight new results from phase 2 trial evaluating dazodalibep in sj gren s syndrome #clinicaltrial 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i